# EDGAR Filing Document

**Accession Number:** 0001595097
**File Stem:** 0001193125-26-113993
**Filing Date:** 2026-3
**Character Count:** 2238
**Document Hash:** 340f9d1622fca4b9960f482695c31540
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-113993.hdr.sgml**: 20260521

**ACCESSION NUMBER**: 0001193125-26-113993

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260318

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Corbus Pharmaceuticals Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001595097
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 464348039
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 500 RIVER RIDGE DRIVE
- **CITY:** NORWOOD
- **STATE:** MA
- **ZIP:** 02062
- **BUSINESS PHONE:** 617-963-0103

**MAIL ADDRESS:**
- **STREET 1:** 500 RIVER RIDGE DRIVE
- **CITY:** NORWOOD
- **STATE:** MA
- **ZIP:** 02062

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SAV Acquisition Corp
- **DATE OF NAME CHANGE:** 20131220

**Corbus Pharmaceuticals Holdings, Inc.**

**500 River Ridge Drive**

**Norwood, MA 02062**

March 18, 2026

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Corbus Pharmaceuticals Holdings, Inc. (the "Company")** |

---

**Registration Statement on Form S-3 (File No. 333-294217)**

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration Statement (the "Registration Statement") be declared effective by the Securities and Exchange Commission at 4:30 p.m., Eastern Time, on March 20, 2026, or as soon as practicable thereafter, or at such later time as the Company or its counsel may request via telephone call to the staff.

Please call Stephen Zapf of Lowenstein Sandler LLP at (973) 422-6708 to confirm the effectiveness of the Registration Statement or with any questions.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | CORBUS PHARMACEUTICALS HOLDINGS, INC. |
| By: | */s/ Sean Moran*  |
| Name: | Sean Moran |
| Title: | Chief Financial Officer |

---

------